FNBP4: A Potential Drug Target for Neurodegenerative Diseases

Target Name: FNBP4

NCBI ID: G23360

FNBP4

FNBP4: A Potential Drug Target for Neurodegenerative Diseases

FNBP4 (FNBP4_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. It is a member of the FNBP4 gene family, which is known for its role in the regulation of neurodegenerative diseases.

One of the unique aspects of FNBP4 is its ability to interact with various signaling pathways, including the TGF-β pathway. This pathway is involved in the development and progression of many diseases, including neurodegenerative disorders.

Research has shown that FNBP4 plays a crucial role in the regulation of neurotransmitter release and synaptic plasticity, which are important for the function of the brain. It has been shown to interact with several neurotransmitters, including dopamine, serotonin, and GABA.

Additionally, FNBP4 has also been shown to play a role in the regulation of ion channels, which are responsible for the flow of electrical signals through the nervous system. This is important for the proper function of the brain and has been implicated in the development of many neurological conditions.

FNBP4 has also been shown to be involved in the regulation of inflammation, which is a crucial aspect of many diseases, including neurodegenerative disorders. This is important for the proper function of the brain and has been implicated in the development of many neurological conditions.

In conclusion, FNBP4 is a protein that has the potential to be a drug target or biomarker for a variety of neurological conditions. Further research is needed to fully understand its role in the regulation of neurodegenerative diseases and to develop effective treatments.

Protein Name: Formin Binding Protein 4

The "FNBP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FNBP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets